Attention and Memory Impairments in Menopausal Women: A Possible Role for Vyvanse?
Phase of Trial: Phase IV
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Cognition disorders
- Focus Therapeutic Use
- 03 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrial.gov.
- 13 Nov 2013 New trial record